SI9420027A - Retarded-action microtablet made of beta-phenylpropiophenone derivatives - Google Patents

Retarded-action microtablet made of beta-phenylpropiophenone derivatives Download PDF

Info

Publication number
SI9420027A
SI9420027A SI9420027A SI9420027A SI9420027A SI 9420027 A SI9420027 A SI 9420027A SI 9420027 A SI9420027 A SI 9420027A SI 9420027 A SI9420027 A SI 9420027A SI 9420027 A SI9420027 A SI 9420027A
Authority
SI
Slovenia
Prior art keywords
weight
active substance
tablet
tablets
release
Prior art date
Application number
SI9420027A
Other languages
English (en)
Slovenian (sl)
Inventor
Karl Kolter
Helmut Fricke
Volker Buehler
Herbert Mueller-Peltzer
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6484646&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9420027(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SI9420027A publication Critical patent/SI9420027A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI9420027A 1993-04-03 1994-03-24 Retarded-action microtablet made of beta-phenylpropiophenone derivatives SI9420027A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4310963A DE4310963C2 (de) 1993-04-03 1993-04-03 Retardmikrotablette von beta-Phenylpropiophenonderivaten

Publications (1)

Publication Number Publication Date
SI9420027A true SI9420027A (en) 1996-08-31

Family

ID=6484646

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420027A SI9420027A (en) 1993-04-03 1994-03-24 Retarded-action microtablet made of beta-phenylpropiophenone derivatives

Country Status (28)

Country Link
US (1) US5681588A (hr)
EP (1) EP0691843B1 (hr)
JP (1) JP3625825B2 (hr)
KR (1) KR100315618B1 (hr)
CN (1) CN1092957C (hr)
AT (1) ATE148988T1 (hr)
AU (1) AU678227B2 (hr)
BR (2) BR9406036A (hr)
CA (1) CA2158166C (hr)
CZ (1) CZ284869B6 (hr)
DE (2) DE4310963C2 (hr)
DK (1) DK0691843T3 (hr)
ES (1) ES2098930T3 (hr)
FI (1) FI114610B (hr)
GR (1) GR3023339T3 (hr)
HR (1) HRP940198B1 (hr)
HU (1) HU221590B (hr)
IL (2) IL109097A0 (hr)
NO (1) NO306848B1 (hr)
NZ (1) NZ263565A (hr)
PL (1) PL175219B1 (hr)
RU (1) RU2157191C2 (hr)
SG (1) SG43955A1 (hr)
SI (1) SI9420027A (hr)
TW (1) TW266159B (hr)
UA (1) UA40616C2 (hr)
WO (1) WO1994022434A1 (hr)
ZA (1) ZA942293B (hr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837292A (en) * 1996-07-03 1998-11-17 Yamanouchi Europe B.V. Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US20050226923A1 (en) * 2004-04-07 2005-10-13 Gassert Chad M Venlafaxine compositions in the form of microtablets
CA2469327A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Propafenone hydrochloride capsules containing microtablets
CA2469339A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Sustained release propafenone hydrochloride capsules
DE102006006532B4 (de) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmazeutische Zubereitung
EP2081550B2 (en) 2006-03-09 2021-05-26 Reliant Pharmaceuticals, Inc. Coating capsules with active pharmaceutical ingredients
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
US20090035370A1 (en) * 2007-08-02 2009-02-05 Drugtech Corporation Dosage form and method of use
WO2010043950A2 (en) 2008-10-15 2010-04-22 Aizant Drug Research Solutions Private Limited Propafenone extended release composition
CN103908443A (zh) * 2013-11-25 2014-07-09 力品药业(厦门)有限公司 一种盐酸普罗帕酮缓释胶囊及其制备方法
CN107441051B (zh) * 2016-05-30 2022-09-16 北京科信必成医药科技发展有限公司 一种盐酸普罗帕酮微片及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951821A (en) * 1972-07-14 1976-04-20 The Dow Chemical Company Disintegrating agent for tablets
DE3210061A1 (de) * 1982-03-19 1983-09-22 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von propafenon
DE3422619A1 (de) * 1984-06-19 1985-12-19 Basf Ag, 6700 Ludwigshafen Zylindrische mikrotabletten
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament
US4753801A (en) * 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
DE3725273A1 (de) * 1987-07-30 1989-02-09 Basf Ag Verfahren zur synthese von enantiomeren des propafenons sowie diese enthaltende therapeutische mittel
DE3809764A1 (de) * 1988-03-23 1989-10-05 Knoll Ag Mischung aus alginaten und polyacrylaten und deren verwendung
US4954347A (en) * 1988-05-03 1990-09-04 Basf K & F Corp. Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
DE3911069A1 (de) * 1989-04-06 1990-10-11 Knoll Ag Einkristalle von ss-phenylpropiophenonen
DE59005781D1 (de) * 1990-07-02 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit.
DE4021678C2 (de) * 1990-07-07 1994-07-07 Merz & Co Gmbh & Co Verfahren zur Herstellung klein dimensionierter Formkörper mit hohem Etofibrat-Gehalt und kontrollierter Wirkstoff-Freisetzung, deren Verwendung und daraus bestehende oral verabreichbare Applikationsformen
IT1250483B (it) * 1990-08-30 1995-04-07 Eurand Int Sistema di ritardo a matrice multipla

Also Published As

Publication number Publication date
ZA942293B (en) 1995-10-02
HRP940198A2 (en) 1996-10-31
GR3023339T3 (en) 1997-08-29
PL175219B1 (pl) 1998-11-30
FI954686A (fi) 1995-10-02
IL109097A (en) 1998-09-24
DE59401833D1 (de) 1997-03-27
CN1120312A (zh) 1996-04-10
US5681588A (en) 1997-10-28
EP0691843B1 (de) 1997-02-19
RU2157191C2 (ru) 2000-10-10
DK0691843T3 (da) 1997-04-28
UA40616C2 (uk) 2001-08-15
CZ284869B6 (cs) 1999-03-17
AU6429594A (en) 1994-10-24
IL109097A0 (en) 1994-06-24
JP3625825B2 (ja) 2005-03-02
PL310966A1 (en) 1996-01-22
SG43955A1 (en) 1997-11-14
BR9406036A (pt) 1995-12-12
KR100315618B1 (ko) 2002-02-28
HRP940198B1 (en) 1997-12-31
AU678227B2 (en) 1997-05-22
FI114610B (fi) 2004-11-30
ES2098930T3 (es) 1997-05-01
BR1100303A (pt) 2002-04-02
CA2158166A1 (en) 1994-10-13
HU9502879D0 (en) 1995-11-28
CA2158166C (en) 2003-10-21
HU221590B (hu) 2002-11-28
NZ263565A (en) 1996-08-27
WO1994022434A1 (de) 1994-10-13
TW266159B (hr) 1995-12-21
EP0691843A1 (de) 1996-01-17
KR960701630A (ko) 1996-03-28
ATE148988T1 (de) 1997-03-15
NO953910D0 (no) 1995-10-02
JPH08508010A (ja) 1996-08-27
FI954686A0 (fi) 1995-10-02
DE4310963A1 (de) 1994-10-06
CZ246595A3 (en) 1996-02-14
NO306848B1 (no) 2000-01-03
HUT73248A (en) 1996-07-29
CN1092957C (zh) 2002-10-23
DE4310963C2 (de) 1997-06-05
NO953910L (no) 1995-10-02

Similar Documents

Publication Publication Date Title
US9931358B2 (en) Direct compression polymer tablet core
EP1392241B1 (en) System for osmotic delivery of pharmaceutically active agents
MXPA06011860A (es) Composiciones farmaceuticas que comprende un almidon anfifilico.
UA73092C2 (uk) Таблетка з ентеросолюбільним покриттям і спосіб її приготування
WO2005060942A1 (en) Extended release pharmaceutical composition of metformin
AU2005320362A1 (en) Controlled release complex formulation for oral administration of medicine for diabetes and method for the preparation thereof
US9387166B2 (en) Controlled release oral dosage form comprising oxycodone
US20110287096A1 (en) Modified gastroretentive drug delivery system for amine drugs
US20140050784A1 (en) Pharmaceutical compositions of memantine
SI9420027A (en) Retarded-action microtablet made of beta-phenylpropiophenone derivatives
WO2010100657A2 (en) A novel oral controlled release dosage forms for water soluble drugs
ES2321908T3 (es) Preparaciones farmaceuticas de liberacion prolongada independientemente del ph.
JP4965096B2 (ja) 圧縮成型製剤
JP3545300B2 (ja) 固体の経口用イフォスファミド医薬組成物およびその製造法
JP2005528388A (ja) 改善された制御放出調製物
CA2437412C (en) Delayed release microtablet of b-phenylpropiophenone derivatives
SK11072000A3 (sk) Tiagabínové prostriedky s predĺženým uvoľňovaním so zníženými vedľajšími účinkami
EP3900708A1 (en) Extended-release medical composition containing zaltoprofen
Tiwari Formulation and characterization of size reduced oral extended release metformin tablets

Legal Events

Date Code Title Description
IF Valid on the event date